On the other hand, resistance to the treatment, despite of high expression of PD-L1 on tumor cells, is observed in some patients treated with immunotherapy and factors that could predict the resistance are being searched for (Sun et al. 2020; Topalian et al. 2019; Elkrief et al. 2019). Here, CD274 is linked to neoplasm.